Stay updated on METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis
Sign up to get notified when there's something new on the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page.

Latest updates to the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page
- Check5 days agoChange DetectedAdded: Revision v3.3.4. Deleted: Revision v3.3.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedMinor content changes: added Revision: v3.3.3 and removed the HHS Vulnerability Disclosure link along with Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedPublications section now notes that publications are automatically filled from PubMed and may not all relate to the study; the revision tag was updated to v3.3.2, replacing v3.2.0.SummaryDifference0.1%

- Check62 days agoChange DetectedThe bottom government operating status notice has been removed. All other study details and navigation remain unchanged.SummaryDifference0.3%

- Check76 days agoChange DetectedPublications section added with related articles and authors. Enrollment and study record dates updated to reflect recent activity for METIMMOX.SummaryDifference0.4%

- Check105 days agoChange DetectedAdded a prominent operating-status notice and version bump to v3.2.0; removed reference to v3.1.0. The page now informs users about potential processing delays and where to check for status.SummaryDifference2%

Stay in the know with updates to METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis
Enter your email address, and we'll notify you when there's something new on the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page.